Canada markets closed

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 03:07PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 2.05M
Enterprise Value 1.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.39
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.28

Trading Information

Stock Price History

Beta (5Y Monthly) -3.53
52-Week Change 3-25.00%
S&P500 52-Week Change 327.86%
52 Week High 30.0350
52 Week Low 30.0100
50-Day Moving Average 30.0211
200-Day Moving Average 30.0162

Share Statistics

Avg Vol (3 month) 355.58k
Avg Vol (10 day) 367.13k
Shares Outstanding 5136.98M
Implied Shares Outstanding 6136.98M
Float 8125.69M
% Held by Insiders 18.16%
% Held by Institutions 10.02%
Shares Short (Mar 15, 2024) 419.99k
Short Ratio (Mar 15, 2024) 40.22
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.01%
Shares Short (prior month Feb 15, 2024) 41.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 10, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.67%
Return on Equity (ttm)-41.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -456.5k
Net Income Avi to Common (ttm)-453k
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.01M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.53
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-675k
Levered Free Cash Flow (ttm)-501.25k